Chronic liver disease negatively affects outcome in hospitalised patients with community-acquired pneumonia

Keywords

• *Community-Acquired Infections
• Humans
• *Liver Diseases
• *Pneumonia
• *bacterial infection
• *chronic liver disease
• Biotest, Boehringer Ingelheim, Noxxon, Quark Pharma, Silence Therapeutics and
• Vaxxilon, and personal fees for lectures or counselling from Actelion, AstraZeneca,
• Bayer HealthCare, Berlin Chemie, Biotest, Boehringer Ingelheim, Chiesi,
• GlaxoSmithKline, Novartis and Vaxxilon. SZ received consultancy and/or lecture
• honoraria from AbbVie, Allergan, Intercept, Janssen, Gilead and Merck/MSD. JT
• received speaking and/or consulting fees from Gore, Bayer, Alexion, MSD, Gilead,
• Intercept, Norgine, Grifols, Versantis and Martin Pharmaceutical, all unrelated to
• the submitted work. GGUR reports personal fees from Pfizer, Boehringer Ingelheim,
• Solvay, GSK, Essex Pharma, MSD, Grifols, Chiesi, Vertex, Roche, Insmed and Novartis
• for lectures including service on speakers' bureaus outside the submitted work
• and/or consultancy during advisory board meeting, and personal fees from GSK for
• travel accommodations/meeting expenses outside the submitted work.